Ignite Creation Date:
2024-05-06 @ 12:29 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03775200
Status:
COMPLETED
Last Update Posted:
2023-04-24
First Post:
2018-12-11
Brief Title:
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Sponsor:
COMPASS Pathways
Organization:
COMPASS Pathways
Study Overview
Official Title:
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
P-TRD
Brief Summary:
The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression
Detailed Description:
The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression - a dose-ranging study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None